Does TACROLIMUS Cause Aplasia pure red cell? 249 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 249 reports of Aplasia pure red cell have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.3% of all adverse event reports for TACROLIMUS.
249
Reports of Aplasia pure red cell with TACROLIMUS
0.3%
of all TACROLIMUS reports
2
Deaths
92
Hospitalizations
How Dangerous Is Aplasia pure red cell From TACROLIMUS?
Of the 249 reports, 2 (0.8%) resulted in death, 92 (36.9%) required hospitalization, and 15 (6.0%) were considered life-threatening.
Is Aplasia pure red cell Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 249 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Aplasia pure red cell?
DARBEPOETIN ALFA (393)
ERYTHROPOIETIN (204)
MYCOPHENOLATE MOFETIL (194)
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (162)
PREDNISONE (103)
PREDNISOLONE (98)
RITUXIMAB (98)
CYCLOSPORINE (90)
METHYLPREDNISOLONE (75)
NIVOLUMAB (73)
Which TACROLIMUS Alternatives Have Lower Aplasia pure red cell Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB